Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Novo Nordisk A/S ADR
(NY:
NVO
)
135.42
UNCHANGED
Streaming Delayed Price
Updated: 7:00 PM EDT, Jul 17, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Novo Nordisk A/S ADR
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
51
52
Next >
8 Pharma Stocks Affected by New Drug Price Negotiation Rules
September 02, 2023
Which companies have the most to lose now that Medicare can negotiate directly with them on the prices of some of the most widely used drugs?
Via
The Motley Fool
The 3 Most Promising Healthcare Stocks to Own Now
September 01, 2023
These top healthcare stock picks are growing revenues by over 30% due to their game-changing medical device products.
Via
InvestorPlace
Jeff Bezos Vs. Elon Musk Space Contract Lawsuit, Novo Nordisk's Famed Drug Ozempic Could Be Next Contender For Medicare Negotiations, Tesla Rival XPeng's August Deliveries Zooms 43%: Today's Top Stories
September 01, 2023
Tech Crunch
Via
Benzinga
Topics
Lawsuit
Exposures
Financial
Legal
Novo Nordisk's Famed Drug Ozempic Could Be Contender For Medicare Negotiations
September 01, 2023
Novo Nordisk A/S's (NYSE: NVO) Ozempic, the highly sought-after diabetes treatment, may soon enter the realm of price negotiations between
Via
Benzinga
$1000 Invested In This Stock 10 Years Ago Would Be Worth $5,600 Today
August 28, 2023
Via
Benzinga
(NVO) - Analyzing Novo Nordisk's Short Interest
August 25, 2023
Via
Benzinga
These Three New Markets May Propel Novo Nordisk's Ozempic To Greater Heights
August 25, 2023
Via
Benzinga
3 Reasons ResMed's CEO Isn't Worried About Ozempic or Wegovy
September 01, 2023
Mick Farrell might be kidding himself about the degree to which the popular weight-loss drugs will impact his company.
Via
The Motley Fool
Novo Nordisk Continues Pursuit Of Obesity-Targeted Companies: Second Acquisition Within A Month
August 30, 2023
Novo Nordisk A/S (NYSE: NVO) continues to bolster its obesity portfolio. In the latest move, the Danish pharma giant has acquired Embark Biotech.
Via
Benzinga
What Impact Will Medicare Price Negotiations Have on Big Pharma Stocks?
August 29, 2023
Investors appear to be yawning for the most part at the latest news on Medicare drug price negotiations.
Via
The Motley Fool
Important Data Ahead, Tesla Turning On Massive Nvidia Cluster, 10 Drugs Name For Price Cuts
August 29, 2023
To gain an edge, this is what you need to know today.
Via
Benzinga
Looking At Novo Nordisk's Recent Unusual Options Activity
August 24, 2023
Via
Benzinga
Does the Red-Hot Weight-Loss Market Make This Pharmaceutical Stock a Buy?
August 29, 2023
The obesity and diabetes epidemics could be enormous opportunities for these seemingly miracle drugs.
Via
The Motley Fool
Biden Targets Cancer, Diabetes Drugs In Controversial Medicare Price Battle
August 29, 2023
The Centers for Medicare and Medicaid Services unveiled the first ten drugs subject to price negotiations under President Joe Biden's Inflation Reduction Act, including:
Via
Benzinga
Blockbusters From AbbVie, Merck, Lilly Highlight List Of 10 Drugs Subject To Price Cuts
August 29, 2023
The Biden administration is planning to negotiate the prices of 10 drugs in 2026.
Via
Investor's Business Daily
Beaten Down COVID-19 Vaccine Partner Stock Catalent Finalizes Deal With Activist Investor, Reports Mixed Q4 Earnings
August 29, 2023
Catalent Inc (NYSE: CTLT), valued at around $8 billion, has finalized a deal with activist investor Elliott Investment Management.
Via
Benzinga
Exposures
COVID-19
Why Wegovy's Sales Potential Could Be Massively Understated
August 29, 2023
Promising results from clinical trials could result in more uses for the popular weight-loss drug.
Via
The Motley Fool
3 Emerging Market Stocks to Buy in August
August 28, 2023
These three emerging market stocks to buy in August will have very strong, positive catalysts going forward.
Via
InvestorPlace
Novo Nordisk's Popular Weight Loss Drug Wegovy Might Be Heavy On Denmark's Healthcare System
August 28, 2023
The Danish Health Ministry released a statement suggesting that reimbursing Novo Nordisk A/S's (NYSE: NVO) weight-loss drug, Wegovy, for the obese population could result in an annual cost of up to $4...
Via
Benzinga
3 Top Growth Stocks I'd Buy Right Now Without Hesitation
August 28, 2023
These drugmakers are all leaders in their respective niches.
Via
The Motley Fool
Is It Time to Take Some Gains in Novo Nordisk Stock? Not So Fast.
August 28, 2023
Novo Nordisk stock has been on a tear, but the company's latest financial report suggests it may just be getting started.
Via
The Motley Fool
How Novo Nordisk, A Top 1% Stock, Just Hit Another Bull's-eye In Obesity Treatment
August 25, 2023
The company tested its drug, Wegovy, in patients with a common form of heart failure.
Via
Investor's Business Daily
Wegovy's Massive Demand: Novo Nordisk CEO Expresses Full Confidence In Catalent Amid Manufacturing Hurdles
August 25, 2023
Novo Nordisk A/S's (NYSE: NVO) CEO, Lars Fruergaard Jorgensen, expressed confidence in Catalent Inc's (NYSE: CTLT) capability to rectify its manufacturing issues related to its
Via
Benzinga
WeWork's Journey From $47B Valuation To Possible Bankruptcy, Mastercard and Visa Reassess Ties with Binance Card, Hawaiian Electric Accused Of Jeopardizing Investigation Of Maui Wildfires: Today's Top Stories
August 25, 2023
Wall Street Journal
Via
Benzinga
Topics
Bankruptcy
Exposures
Financial
Legal
Novo Nordisk's Weight Loss Treatment Shows Benefit In Patients With Most Common Type Of Heart Failure
August 25, 2023
Novo Nordisk A/S (NYSE: NVO) announced resul
Via
Benzinga
Novo Nordisk Eyes Social Inequality To Enhance Access To Wegovy: 'Have To Be More Intentional'
August 25, 2023
Via
Benzinga
This New Development Is Helping to Send Eli Lilly and Novo Nordisk Stocks Soaring
August 24, 2023
Some of their winning medicines could soon compete in new markets.
Via
The Motley Fool
3 Massive New Markets Could Await Ozempic, And They Might Make Novo Nordisk Investors Richer
August 24, 2023
It'll take some time to try to enter those markets, but the upside could be huge.
Via
The Motley Fool
Why Novo Nordisk Stock Was Racing Higher on Wednesday
August 23, 2023
When you have a hot item on the market, it's wise to ramp up production.
Via
The Motley Fool
Airbnb Versus New York Regulations, Netflix Adds New US Users After Password Crackdown, Facebook Marketplace Under Regulatory Fire For Alleged Sale Of Recalled Items: Top Stories
August 23, 2023
Wall Street Journal Airbnb Versus New York: What's Going On?
Via
Benzinga
< Previous
1
2
...
29
30
31
32
33
34
35
36
37
...
51
52
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.